Authors




David Hileman, RPh

Latest:

Where's the Special in Specialty? Has the Increase in the Number of Players Diluted Services?

The growing cost of specialty products places greater importance on the support that patients receive.



Randy McDonough, Towncrest Pharmacy

Latest:

2010 Lifetime Achievement: Randy McDonough

Randy McDonough has bettered the field through his tireless work on behalf of patients, with a special focus on medication therapy management.




Neil B. Minkoff, MD

Latest:

Pharmacosynchrony: Road Map to Transformation in Pharmacy Benefit Management

Pharmacosynchrony is the application of innovative clinical, analytic, and technologic pharmacy solutions to drive improved care coordination and higher-quality, more patient-centered care.



Paul Sipes

Latest:

The Real Scoop on Data Warehouses

The implementation of a data warehouse, a relational database for query and analysis, can help a specialty pharmacy utilize its data to the fullest.


Ketra Deschamps, RN, BSN

Latest:

Do Units and Costs of Comparable Insulins Differ by Manufacturer?

Patient characteristics and product mix play an important role in determining the overall use and costs of comparable insulins across different manufacturers.


Matityahu Berkovitch, MD

Latest:

Large-Scale, Community-Based Trial of a Personalized Drug-Related Problem Rectification System

A controlled trial of a system for rectifying and preventing drug-related problems was conducted to evaluate improvement in the efficiency of resource utilization.


Marketing, Sentry Data SystemsÂ

Latest:

Mitigating Drug Diversion Risk: More Than Just Narcotics, Specialty Needs to Look at This Growing Problem

Expensive specialty drugs are a growing concern that are traditionally overlooked in drug diversion efforts.


Jason W. Lancaster, PharmD, BCPS

Latest:

Economic Impact of Fidaxomicin on CDI Treatment in United States

Fidaxomicin has shown promise as an effective treatment option for Clostridium difficile infections, but no pharmacoeconomic studies have been performed to date.


Rahman Gul, PharmD Candidate

Latest:

Ozanimod: Treatment for Relapsing Forms of Multiple Sclerosis

Ozanimod (Zeposia) became the third oral S1P modulator approved by the FDA for the treatment of multiple sclerosis,


Amy Jacob, HCPLive

Latest:

Does Treatment with Antidepressants Benefit Esophageal Disorders?

A systematic review recently reported that antidepressants were beneficial for GERD patients " curbing esophageal sensation and reducing functional chest pain.


Kimberly McKeirnan, PharmD

Latest:

CDC Report Highlights Current Trends in Opioid Prescriptions

The recently released CDC Annual Surveillance Report of Drug-Related Risks and Outcomes presents a clearer picture for how has opioid prescribing been trending in the last 3 years.


William Soliman, PhD, MPhil, MA

Latest:

Opinion: The Opioid Crisis: Where Does Pharma Go From Here?

After the Oklahoma case ruling, Johnson & Johnson stocks rallied, but the ruling is a warning to industry leaders that change is necessary.


Wanda Lingner, RN, BSN

Latest:

Sharps Disposal: Assuring Regulatory Compliance During Off-Site Vaccination Clinics

Innovative pharmacists have taken immunizations, including the influenza vaccine, to off-site clinics located at employer sites, churches, malls, and various other community locations, with the intent to keep people healthy during the annual flu season rather than having them experience extended illnesses and loss of productivity.


Elizabeth A. Tolley, PhD

Latest:

Cost Outcomes of Diabetes Education in a Specialized Community Pharmacy

Diabetes management offered by an employer group in a self-funded health plan over 3 years resulted in significant cost savings and improved patient outcomes.


Feng Cao, PhD

Latest:

Lung Cancer: Copayments and Behavior Following Erlotinib Formulary Tier Change

Moving erlotinib from formulary tier 3 to tier 2 resulted in lower copayments and higher treatment persistence among lung cancer patients.




Sean Kane, PharmD

Latest:

Top 200 Drugs of 2018: Which Ones Are Making an Impact?

The latest DrugStats database list shows the medications with increasing numbers of prescriptions.




Ellen Kurek

Latest:

How Biomarkers Can Improve Early Diagnosis of Multiple Sclerosis

A lack of biomarkers can result in a delay in multiple sclerosis diagnosis and treatment.


Michael Einodshofer, RPh, MBA

Latest:

The Challenge of Specialty Pharmacy: Mitigating Costs While Providing Quality Care

The cost of complex therapies is soaring, and the challenge is to deliver access to these medications in the most cost-effective and clinically appropriate site of service.


Belinda Sam, PharmD Candidate

Latest:

New Insulin Products and Best Practices

Even with many new developments over the past century, the coordinated use of blood glucose monitors, diabetes medications, and insulin to manage the disease may be too intricate for some patients.